Efficacy and Safety of Frontline Rituximab, Cyclophosphamide, Doxorubicin and Prednisone Plus Bortezomib (VR-CAP) or Vincristine (R-CHOP) in a Subset of Newly Diagnosed Mantle Cell Lymphoma Patients Medically Eligible for Transplantation in the Randomized, Phase 3 LYM-3002 Study
Leukemia & lymphoma/Leukemia and lymphoma（2018）
Key words
Bortezomib,frontline,mantle cell lymphoma,phase 3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined